Company Overview and News


Add MYX
to your dashboard

Headline News

Last week for tax-loss selling before the July bounce

2017-06-18 theage.com.au
Tax loss selling has hammered some shares this season, but the strategy is gearing up to have one last wash through the ASX this week before the July pickup.

Last week for tax-loss selling before the July bounce

2017-06-18 smh.com.au
Tax loss selling has hammered some shares this season, but the strategy is gearing up to have one last wash through the ASX this week before the July pickup.

Twenty U.S. states join generic drug price-fixing lawsuit

2017-03-01 reuters
WASHINGTON, March 1 California, Illinois and 18 more states have joined a lawsuit filed last year alleging that six companies, including Mylan NV and Teva Pharmaceutical Industries Ltd, conspired to push up prices of two generic drugs, the Connecticut attorney general's office said on Wednesday.

FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Impax Laboratories Inc. (IPXL) and Lead Plaintiff Deadline: January 9, 2017

2017-01-09 accesswire
NEW YORK, NY / ACCESSWIRE / January 9, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Impax between February 25, 2014 and November 3, 2016, both dates inclusive (the "Class Period").

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017

2017-01-05 accesswire
NEW YORK, NY / ACCESSWIRE / January 5, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lannett Company Inc. ("Lannett" or the "Company") (NYSE: LCI) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Lannett securities between September 12, 2013 and November 3, 2016, both dates inclusive (the "Class Period").

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Impax Laboratories Inc. (IPXL) and Lead Plaintiff Deadline: January 9, 2017

2017-01-04 accesswire
NEW YORK, NY / ACCESSWIRE / January 4, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Impax between February 25, 2014 and November 3, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017

2016-12-29 accesswire
NEW YORK, NY / ACCESSWIRE / December 29, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lannett Company Inc. ("Lannett" or the "Company") (NYSE: LCI) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Lannett securities between September 12, 2013 and November 3, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo International PLC (ENDP) and Lead Plaintiff Deadline: January 6, 2017

2016-12-28 accesswire
NEW YORK, NY / ACCESSWIRE / December 28, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Endo International PLC ("Endo" or the "Company") (NASDAQ: ENDP) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Endo between September 28, 2015 and November 2, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Impax Laboratories Inc. (IPXL) and Lead Plaintiff Deadline - January 9, 2017

2016-12-28 accesswire
NEW YORK, NY / ACCESSWIRE / December 28, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Impax between February 25, 2014 and November 3, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017

2016-12-22 accesswire
NEW YORK, NY / ACCESSWIRE / December 22, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lannett Company Inc. ("Lannett" or the "Company") (NYSE: LCI) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Lannett securities between September 12, 2013 and November 3, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo International PLC (ENDP) and Lead Plaintiff Deadline: January 6, 2017

2016-12-20 accesswire
NEW YORK, NY / ACCESSWIRE / December 20, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Endo International PLC ("Endo" or the "Company") (NASDAQ: ENDP) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Endo between September 28, 2015 and November 2, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Impax Laboratories Inc. (IPXL) and Lead Plaintiff Deadline - January 9, 2017

2016-12-20 accesswire
NEW YORK, NY / ACCESSWIRE / December 20, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Impax between February 25, 2014 and November 3, 2016, both dates inclusive (the "Class Period").

US lawmakers press Heritage Pharma on high prices for antibiotic

2016-12-16 channelnewsasia
WASHINGTON: Two U.S. lawmakers are questioning whether Heritage Pharmaceuticals misled them in response to a 2014 congressional inquiry about the rising price a common antibiotic, after 20 U.S. states this week accused the company of price fixing.

Mylan, Teva, Mayne Sued By 20 States Over Drug Price Fixing

2016-12-16 fortune
Shares in Mayne Pharma Group maynf plunged as much as 24% on Friday after several U.S. states filed a lawsuit alleging the Australian pharmaceutical firm had engaged in a conspiracy with others to fix prices on two generic drugs.

UPDATE 1-Australia's Mayne Pharma Group shares tumble on U.S. lawsuit

2016-12-16 reuters
SYDNEY Dec 16 Shares in Australian pharmaceutical company Mayne Pharma Group Ltd fell more than 16 percent on Friday after 20 U.S states filed a lawsuit against it alleging it engaged in a conspiracy with others to fix prices on two generic drugs.

Mayne Pharma shares dive on US price fixing lawsuit

2016-12-16 theage.com.au
Shares in pharmaceutical company Mayne Pharma Group fell more than 16 per cent on Friday after 20 US states filed a lawsuit against it alleging it engaged in a conspiracy with others to fix prices on two generic drugs.

Mayne Pharma shares dive on US price fixing lawsuit

2016-12-16 smh.com.au
Shares in pharmaceutical company Mayne Pharma Group fell more than 16 per cent on Friday after 20 US states filed a lawsuit against it alleging it engaged in a conspiracy with others to fix prices on two generic drugs.

TEVA, MYL Among Six Drug Makers Accused of Price Fixing in U.S.

2016-12-15 investorplace
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is one of six companies being named as part of a price fixing scandal in the U.S.

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017

2016-12-15 accesswire
NEW YORK, NY / ACCESSWIRE / December 15, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lannett Company Inc. ("Lannett" or the "Company") (NYSE: LCI) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Lannett securities between September 12, 2013 and November 3, 2016, both dates inclusive (the "Class Period").

Sacked executives of Emcure’s US unit to enter guilty pleas in US generics case

2016-12-15 livemint
Executives’ cooperation could lead to charges against executives at other drugmakers in probe of price fixing in generics drugs

US files first charges in generic drug price-fixing probe

2016-12-15 moneycontrol
The two men are in talks with the government about a plea agreement, according to a source close to the negotiations who was not authorized to discuss the matter.

U.S. Files First Charges in Generic Drug Price-Fixing Probe - Bloomberg

2016-12-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Impax Laboratories Inc. (IPXL) and Lead Plaintiff Deadline - January 9, 2017

2016-12-13 accesswire
NEW YORK, NY / ACCESSWIRE / December 13, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Impax between February 25, 2014 and November 3, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo International PLC (ENDP) & Lead Plaintiff Deadline: January 6, 2017

2016-12-13 accesswire
NEW YORK, NY / ACCESSWIRE / December 13, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Endo International PLC ("Endo" or the "Company") (NASDAQ: ENDP) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Endo between September 28, 2015 and November 2, 2016, both dates inclusive (the "Class Period").

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Lannett Company, Inc.

2016-12-01 prnewswire
WAYNE, Pa., Dec. 1, 2016 /PRNewswire/ -- Ryan & Maniskas, LLP announces that a class action lawsuit has been filed in United States District Court for the Eastern District of Pennsylvania on behalf of all persons or entities that purchased Lannett Company, Inc. (NYSE: LCI) ("Lannett" or the "Company") common shares between September 12, 2013 and November 3, 2016, inclusive (the "Class Period").